Clinical Trial Update: Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the pharmacokinetic interaction between PLA-695 and methotrexate in adults with rheumatoid arthritis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• PLA-695

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED